CBD Hemp Oil Market at more than US$ 950.0 Mn in 2017 and is projected to surpass US$ 2.5 Bn by 2026

The global CBD hemp oil market is expanding owing to with increasing prevalence of chronic and infectious diseases across the globe. The global CBD hemp oil market was valued at more than US$ 950.0 Mn in 2017 and is projected to surpass US$ 2.5 Bn by 2026, expanding at a compound annual growth rate (CAGR) of more than 11% from 2018 to 2026.

CBD Hemp Oil Market – Snapshot

The global market is witnessing expansion at a relatively higher growth rate owing to increasing expenditure on health care, high incidences of chronic diseases, and, rising awareness about treating sleep disorder & depression among patients.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111986

CBD hemp oil is considered as a crucial mixture of chemical components that control diseases and help in treatment of the patients diagnosed with neurological disorders and other diseases. CBD hemp oil is derived from an organic substance formed from the plant’s secretions. Delta-9 tetrahydrocannabinol, or THC chemical constituent of oil, is gaining momentum in the scientific community and media for the usage of europrotection, stress relief, immune response, and regulating the body’s general state of balance.

CBD hemp oil aids patients suffering from different chronic diseases as well as increases the ability of a body to produce natural cannabinoids in order to improve the immune system. High prevalence and incidence rates of chronic diseases such as cancer and diabetes, increased focus on decreasing stress & depression among the young generation, and rising concerns over the spread of neurological disorders have led to an increase in usage of CBD hemp oil for treatment procedures. These factors, collectively, are projected to drive the global CBD hemp oil market in the near future. Furthermore, technological advancements, such as increasing usage of CBD hemp oil in the form of spray, vape, and tincture, are estimated to fuel the CBD hemp oil market in the near future.

The global CBD hemp oil market has been broadly segmented based on product, application, distribution channel, and region. In terms of product, the global market has been classified into hemp-based and marijuana-based. The hemp-based segment accounted for a key share (in terms of revenue) of the global market in 2017. The marijuana-based segment is estimated to expand at a significant growth rate during the forecast period. These product segments are estimated to gain considerable market share by the end of 2026. In terms of application, use of CBD hemp oil in neurological pain treatment is increasingly gaining popularity among health care providers, commercial users, and domestic users. These factors are likely to fuel the neurological pain segment during the forecast period.

View full report@ https://qyresearchmedical.com/report/cbd-hemp-oil-market-product-hemp-based-marijuana-based-application-sleeping-disorders-and-depression-multiple-sclerosis-neurological-pain-distribution-channel-hospital-pharmacies-retail-pharmacies-onli-018-2030/111986

In terms of distribution channel, the global CBD hemp oil market has been segregated into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment dominates the global market and is likely to maintain its dominance, and gain market share, marginally, by the end of 2026. Increasing number of incidences of multiple sclerosis, cancer, diabetes, etc., is likely to boost the frequency of usage of CBD hemp oil, and increase in per capita income on healthcare expenditure are few value added features that are likely to drive the CBD hemp oil market as well as boost the hospital pharmacies segment during the forecast period. Increasing number of hospital pharmacies in emerging economies has led to the prominent share by the segment in the global market. The online pharmacies segment of the CBD hemp oil market is likely to expand at a prominent CAGR during forecast period due to easy regulations on sale of CBD hemp oil in several countries.

In terms of region, the global CBD hemp oil market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market; however, it is projected to gain market share by the end of 2026. The market in North America is primarily driven by the rapidly increasing geriatric population and their admission to hospitals due to chronic disease, high adoption of treatment procedure, and the rising incidence of neurological pain among the population in the U.S. Moreover, increasing production of cannabis and legalization on the sale of cannabis in Canada is projected to fuel the hemp based segment of the market in the North America during the forecast period. The CBD hemp oil market in Asia Pacific is projected to expand at a rapid pace during the forecast period. China dominated the CBD hemp oil market in Asia Pacific, while the market in Japan and India is estimated to expand at a significant CAGR during the forecast period.

Companies such as ENDOCA, Medical Marijuana, Cannoid, Canopy Growth Corporation and Elixinol Global Limited accounted for a major share of the global CBD hemp oil market in 2017. In April 2018, Elixinol Global announced an agricultural operations extension in the state of Colorado, U.S. with Kersey Agricultural Company. This is expected to increase the company’s hemp and CBD supply chain in the near future. Other global players operating in the market include Isodiol, NuLeaf Naturals, PharmaHemp, Aphria Inc., and Folium Biosciences, who are focused on strategic acquisitions and collaborations with parallel companies in order to improve and strengthen their geographic presence in the international market.

The medicinal cannabis industry is expanding due to use of cannabidiol (CBD) in various medical applications. Rise in utilization of cannabidiol can be attributed to increase in legalization of medicinal cannabis and societal acceptance. Moreover, FDA approval of CBD hemp oil for the treatment of epilepsy has increased its use in the pharmaceutical industry. Hence, companies continue to improve the medicated solutions through enhanced CBD-based medication.

SanSal Wellness, committed to the research & development of improved hemp genetics cultivation and innovation, provides the global community with uncompromised quality hemp products, containing the highest quality, quantity, and consistency in the industry.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111986/2900

NightFood Holdings, Inc., a brand development company, projected billion-dollar investment in nutrition category by developing unique products based on marijuana/cannabis/CBD.

Musculoskeletal conditions are a common cause for severe long-term pain and physical disability. Prevalence and incidence of musculoskeletal conditions increase with age. Pain and physical disability affect musculoskeletal functions and mental health. A report published by the journal Osteoarthritis Cartilage indicated that nearly 27 million adults in the U.S. and 8.5 million adults in the U.K. are estimated to have osteoarthritis (OA).

Global CBD hemp oil market is segmented as given below:

Product

  • Hemp Based
  • Marijuana Based

Application

  • Sleeping Disorders & Depression
  • Multiple Sclerosis
  • Neurological Pain
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global CBD Hemp Oil Market

4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2.  Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global CBD Hemp Oil Market Analysis and Forecasts, 2016–2026
4.4.1. Global CBD Hemp Oil Market Revenue Projections (US$ Mn)
4.5. Market Outlook
4.6.Regulatory Scenarios
4.7.Snapshot of Global Production of Cannabis
4.8.Epidemiological Data for Cannabis Use and Dependence

5. Global CBD Hemp Oil Market Analysis and Forecast, by Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Global CBD Hemp Oil Market Value Forecast, by Product, 2016–2026
5.3.1. Hemp  Based
5.3.2. Marijuana Based
5.4. Global CBD Hemp Oil Market Attractiveness, by Product

6. Global CBD Hemp Oil Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global CBD Hemp Oil Market Value Forecast, by Application, 2016–2026
6.3.1. Sleeping Disorders & Depression
6.3.2. Multiple Sclerosis
6.3.3. Neurological Pain
6.3.4. Others
6.4. Global CBD Hemp Oil Market Attractiveness, by Application

7. Global CBD Hemp Oil Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global CBD Hemp Oil Market Value Forecast, by Distribution Channel, 2016–2026
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.3.4. Others
7.4. Global CBD Hemp Oil Market Attractiveness, by Distribution Channel

8. Global CBD Hemp Oil Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region

9. North America CBD Hemp Oil Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America CBD Hemp Oil Market Value Forecast, by Product, 2016–2026
9.2.1. Hemp  Based
9.2.2. Marijuana Based
9.3. North America CBD Hemp Oil Market Value Forecast, by Application, 2016–2026
9.3.1. Sleeping Disorders & Depression
9.3.2. Multiple Sclerosis
9.3.3. Neurological Pain
9.3.4. Others
9.4. North America CBD Hemp Oil Market Value Forecast, by Distribution Channel  , 2016–2026
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.4.4. Others
9.5. North America CBD Hemp Oil Market Value Forecast, by Country, 2016–2026
9.5.1. U.S.
9.5.2. Canada
9.6. North America CBD Hemp Oil Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By Distribution Channel
9.6.4. By Country

10. Europe CBD Hemp Oil Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2. Europe CBD Hemp Oil Market Value Forecast, by Product, 2016–2026
10.2.1. Hemp  Based
10.2.2. Marijuana Based
10.3. Europe CBD Hemp Oil Market Value Forecast, by Application, 2016–2026
10.3.1. Sleeping Disorders & Depression
10.3.2. Multiple Sclerosis
10.3.3. Neurological Pain
10.3.4. Others
10.4. Europe CBD Hemp Oil Market Value Forecast, by Distribution Channel  , 2016–2026
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Others
10.5. Europe CBD Hemp Oil Market Value Forecast, by Country, 2016–2026
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe CBD Hemp Oil Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By Distribution Channel
10.6.4. By Country

11. Asia Pacific CBD Hemp Oil Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. Asia Pacific CBD Hemp Oil Market Value Forecast, by Product, 2016–2026
11.2.1. Hemp  Based
11.2.2. Marijuana Based
11.3. Asia Pacific CBD Hemp Oil Market Value Forecast, by Application, 2016–2026
11.3.1. Sleeping Disorders & Depression
11.3.2. Multiple Sclerosis
11.3.3. Neurological Pain
11.3.4. Others
11.4. Asia Pacific CBD Hemp Oil Market Value Forecast, by Distribution Channel  , 2016–2026
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Others
11.5. Asia Pacific CBD Hemp Oil Market Value Forecast, by Country, 2016–2026
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific CBD Hemp Oil Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By Distribution Channel
11.6.4. By Country

12. Latin America CBD Hemp Oil Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Latin America CBD Hemp Oil Market Value Forecast, by Product, 2016–2026
12.2.1. Hemp  Based
12.2.2. Marijuana Based
12.3. Latin America CBD Hemp Oil Market Value Forecast, by Application, 2016–2026
12.3.1. Sleeping Disorders & Depression
12.3.2. Multiple Sclerosis
12.3.3. Neurological Pain
12.3.4. Others
12.4. Latin America CBD Hemp Oil Market Value Forecast, by Distribution Channel  , 2016–2026
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.4.4. Others
12.5. Latin America CBD Hemp Oil Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America CBD Hemp Oil Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Middle East & Africa CBD Hemp Oil Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Middle East & Africa CBD Hemp Oil Market Value Forecast, by Product, 2016–2026
13.2.1. Hemp  Based
13.2.2. Marijuana Based
13.3. Middle East & Africa CBD Hemp Oil Market Value Forecast, by Application, 2016–2026
13.3.1. Sleeping Disorders & Depression
13.3.2. Multiple Sclerosis
13.3.3. Neurological Pain
13.3.4. Others
13.4. Middle East & Africa CBD Hemp Oil Market Value Forecast, by Distribution Channel  , 2016–2026
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.4.4. Others
13.5. Middle East & Africa CBD Hemp Oil Market Value Forecast, by Country/Sub-regions, 2016–2026
13.5.1. GCC countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Middle East & Africa CBD Hemp Oil Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-regions

14. Competition Landscape
14.1.Market Player – Competition Matrix (By Tier and Size of companies)
14.2.Global CBD Hemp Oil Market Snapshot of Companies (2017)
14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. ENDOCA
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Isodiol
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Medical Marijuana
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Cannoid
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Canopy Growth Corporation
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Elixinol Group
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.6.5. Financial
14.3.7. Folium Biosciences
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. NuLeaf Naturals
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. PharmaHemp
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Aphria Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111986/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi